Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
therapeutics tags : Designation save search
Lexeo Therapeutics Granted FDA Fast Track Designation for LX2006, an AAV-Based Gene Therapy Candidate for the Treatment of Friedreich’s Ataxia Cardiomyopathy
Published: 2024-04-16 (Crawled : 12:00) - globenewswire.com
LXEO | $12.1 -1.31% -1.32% 83K
|
|
| O: 5.32%
H: 0.0%
C: -2.63%
lx2006 fda candidate granted treatment designation for therapeutics therapy
Candel Therapeutics Receives FDA Orphan Drug Designation for CAN-2409 for the Treatment of Pancreatic Cancer
Published: 2024-04-11 (Crawled : 13:00) - globenewswire.com
CADL | $5.49 0.92% 0.91% 740K
|
|
| O: 25.49%
H: 23.75%
C: 13.75%
can-2409 fda drug cancer pancreatic treatment designation for therapeutics
Lisata Therapeutics Announces U.S. FDA Orphan Drug Designation Granted to LSTA1 for the Treatment of Osteosarcoma
Published: 2024-04-09 (Crawled : 12:30) - globenewswire.com
LSTA | $2.78 -5.82% 1.1K
|
Manufacturing
|
| O: 0.34%
H: 9.62%
C: 3.78%
fda drug granted treatment designation for therapeutics
Lisata Therapeutics Announces U.S. FDA Rare Pediatric Disease Designation Granted to LSTA1 for the Treatment of Osteosarcoma
Published: 2024-03-21 (Crawled : 12:00) - globenewswire.com
LSTA | $2.78 -5.82% 1.1K
|
Manufacturing
|
| O: 0.32%
H: 9.68%
C: 8.06%
fda rare disease granted treatment designation therapeutics
Keros Therapeutics Announces U.S. FDA Fast Track Designation for KER-050 in Lower-Risk Myelodysplastic Syndromes
Published: 2024-03-14 (Crawled : 12:00) - globenewswire.com
KROS | $59.08 -0.32% -0.32% 300K
|
Health Technology
|
| O: -0.95%
H: 0.34%
C: -3.27%
ker-050 fda designation therapeutics
Poseida Therapeutics Announces FDA Orphan Drug Designation Granted to P-BCMA-ALLO1 for the Treatment of Multiple Myeloma
Published: 2024-03-13 (Crawled : 20:00) - prnewswire.com
PSTX | News | $2.005 -1.72% -1.75% 520K
|
Health Technology
|
| O: -0.88%
H: 0.0%
C: -4.14%
fda drug granted treatment designation therapeutics
Unicycive Therapeutics Announces Orphan Drug Designation Granted for UNI-494 by the U.S. Food and Drug Administration for the Prevention of Delayed Graft Function in Kidney Transplant Patients
Published: 2024-03-04 (Crawled : 12:00) - globenewswire.com
UNCY | $1.09 -5.63% -5.96% 890K
|
Professional, Scientific, and T...
|
| O: 1.25%
H: 2.46%
C: -8.02%
uni-494 drug kidney granted food designation therapeutics
Better Therapeutics Receives FDA Breakthrough Device Designation for Digital Therapeutic Platform Targeting Advanced Liver Disease
Published: 2024-02-20 (Crawled : 15:30) - biospace.com/
BTTX | $0.009 -65.02% 180K
|
|
| O: 7.55%
H: 2.13%
C: -27.83%
fda device liver disease designation therapeutics advanced platform
Edgewise Receives U.S. FDA Fast Track Designation for EDG-5506 for the Treatment of Duchenne Muscular Dystrophy (Duchenne)
Published: 2024-02-13 (Crawled : 15:00) - biospace.com/
EWTX | $15.43 -1.41% -1.43% 530K
|
Manufacturing
|
| O: -2.9%
H: 2.99%
C: 2.77%
edg-5506 fda treatment designation duchenne
CAN-3110 Receives FDA Fast Track Designation for Treatment of Recurrent High-Grade Glioma
Published: 2024-02-13 (Crawled : 12:30) - globenewswire.com
CADL | $5.49 0.92% 0.91% 740K
|
|
| O: 7.19%
H: 30.2%
C: 20.81%
can-3110 fda treatment designation
BioXcel Therapeutics Receives FDA Fast Track Designation for BXCL701 for Treatment of Small Cell Neuroendocrine Prostate Cancer (SCNC)
Published: 2024-02-12 (Crawled : 12:00) - globenewswire.com
BTAI | $2.56 -1.16% -1.17% 240K
|
Health Technology
|
| O: 13.74%
H: 2.08%
C: -18.75%
bxcl701 fda cancer cell treatment designation therapeutics
4DMT Receives Rare Pediatric Disease Designation from FDA for Aerosolized 4D-710 for Treatment of Cystic Fibrosis Lung Disease
Published: 2024-01-23 (Crawled : 13:00) - globenewswire.com
FDMT | News | $24.71 -2.33% -2.39% 420K
|
Health Technology
|
| O: 2.08%
H: 3.85%
C: 1.65%
fda rare lung disease treatment fibrosis designation
Nurix Therapeutics Receives U.S. FDA Fast Track Designation for NX-5948 for the Treatment of Relapsed or Refractory CLL and SLL
Published: 2024-01-16 (Crawled : 21:00) - globenewswire.com
NRIX 2 d | $14.43 2.49% 2.43% 970K
|
Health Technology
|
| O: -3.21%
H: 3.32%
C: -0.36%
nx-5948 fda treatment designation therapeutics
Seres Therapeutics Announces VOWST™ Commercial Launch Update and US FDA Fast Track Designation for SER-155
Published: 2024-01-09 (Crawled : 14:00) - biospace.com/
MCRB | $0.589 -6.11% -6.5% 3.8M
|
Health Technology
|
| O: 26.92%
H: 3.54%
C: -27.78%
ser-155 fda update designation commercial therapeutics
Better Therapeutics Announces Submission for FDA Breakthrough Device Designation for Digital Therapeutic Platform to Treat Liver Disease
Published: 2024-01-02 (Crawled : 13:00) - biospace.com/
BTTX | $0.009 -65.02% 180K
|
|
| O: 4.1%
H: 0.3%
C: -10.0%
fda device liver disease treat designation therapeutics platform submission
4DMT Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for 4D-150 Genetic Medicine for Intravitreal Treatment of Wet AMD, the First RMAT Designation in Wet AMD
Published: 2023-12-21 (Crawled : 13:00) - globenewswire.com
FDMT | News | $24.71 -2.33% -2.39% 420K
|
Health Technology
|
| O: 3.04%
H: 7.13%
C: 4.18%
fda rmat first genetic treatment designation advanced therapy
Innovent and AnHeart Therapeutics Announce the National Medical Products Administration of China Has Granted Taletrectinib (ROS1 Inhibitor) Priority Review Designation
Published: 2023-12-19 (Crawled : 00:00) - prnewswire.com
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.45%
H: 0.0%
C: 0.0%
INCY | $52.82 0.19% 0.19% 1.8M
|
Health Technology
|
| O: 0.58%
H: 2.12%
C: 1.53%
granted review designation medical therapeutics china
Lexeo Therapeutics Granted FDA Fast Track Designation and Orphan Drug Designation for LX2020, an AAV-Based Gene Therapy Candidate for PKP2 Arrhythmogenic Cardiomyopathy (ACM)
Published: 2023-12-18 (Crawled : 12:00) - globenewswire.com
LXEO | $12.1 -1.31% -1.32% 83K
|
|
| O: -0.08%
H: 15.92%
C: 8.8%
lx2020 fda drug candidate granted designation therapeutics therapy
Viracta Therapeutics Announces Orphan Drug Designation Granted by the U.S. FDA to Nana-val for the Treatment of Nasopharyngeal Carcinoma
Published: 2023-12-12 (Crawled : 13:00) - globenewswire.com
VIRX | $0.8971 -4.18% -4.36% 79K
|
Manufacturing
|
| O: 1.63%
H: 1.94%
C: -7.78%
fda drug granted treatment designation therapeutics
Candel Therapeutics Receives FDA Fast Track Designation for CAN-2409 in Pancreatic Cancer
Published: 2023-12-12 (Crawled : 13:00) - globenewswire.com
CADL | $5.49 0.92% 0.91% 740K
|
|
| O: 55.44%
H: 8.15%
C: -25.19%
can-2409 fda cancer pancreatic designation therapeutics
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.